Richard Schulick, MD, MBA, FACS
Disclosures: Royalty-Co-Inventor of Patent-Aduro Biotech-coinventor of a patent that uses genetically modified Listeria to treat cancer. It is licensed to Aduro Biotech. This is managed by Johns Hopkins University,Consulting Fee-grandrounds.com-Other_Role-consultant to grandrounds.com which seeks expert consults for patients who contact them. This is managed by the University of Colorado,Royalty-GlaxoSmithKline-Other_Role-coinvertor of patent that uses CD112 pathway to alter immune response. Managed by University of Colorado,On Board of NOILE Immune. Not compensated-Other_Role
No Bio Available.